PXMD | NVO | VRTX | REGN | SGEN | ALNY | |
---|---|---|---|---|---|---|
Company Name | PaxMedica, Inc. Common Stock | Novo Nordisk A/S | Vertex Pharmaceuticals Incorporated | Regeneron Pharmaceuticals, Inc. | Seagen Inc. | Alnylam Pharmaceuticals, Inc. |
Sector | Healthcare | Healthcare | Healthcare | Healthcare | Healthcare | Healthcare |
Industry | Biotechnology | Biotechnology | Biotechnology | Biotechnology | Biotechnology | Biotechnology |
Market Cap | $1.20M | $555.15B | $119.18B | $111.79B | $43.15B | $35.01B |
Employees | 0.01K | 69.26K | 5.40K | 13.93K | 3.26K | 2.10K |
CEO | Mr. Howard J. Weisman | Mr. Lars Fruergaard Jorgensen | Dr. Reshma Kewalramani FASN, M.D. | Dr. Leonard S. Schleifer M.D., Ph.D. | Mr. David R. Epstein B.Sc., M.B.A. | Dr. Yvonne L. Greenstreet M.B.A., MBChB |